SULFORAPHANE ALLEVIATES POSTRESUSCITATION LUNG PYROPTOSIS POSSIBLY VIA ACTIVATING THE NRF2/HO-1 PATHWAY

被引:5
|
作者
Li, Yulin [1 ,2 ,3 ]
Yang, Minfei [1 ,2 ,3 ]
Xie, Lutao [1 ,4 ]
Zhang, Gongping [1 ,4 ]
Xu, Jiefeng [1 ,2 ,3 ]
Xu, Shanxiang [1 ,2 ,3 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Emergency Med, 88 Jiefang Rd, Hangzhou 310009, Peoples R China
[2] Key Lab Diag & Treatment Severe Trauma & Burn Zhej, Hangzhou, Peoples R China
[3] Zhejiang Prov Clin Res Ctr Emergency & Crit Care, Hangzhou, Peoples R China
[4] Lishui Muncipal Cent Hosp, Dept Emergency Med, Lishui, Peoples R China
来源
SHOCK | 2023年 / 60卷 / 03期
关键词
Sulforaphane; cardiopulmonary resuscitation; lung injury; pyroptosis; Nrf2/HO-1; pathway; HEART-ASSOCIATION GUIDELINES; CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; INJURY; MECHANISM; OUTCOMES; NRF2; CARE;
D O I
10.1097/SHK.0000000000002180
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Sulforaphane (SFN), known as the activator of the nuclear factor E2-related factor 2 (Nrf2)/heme oxygenase 1 (HO-1) pathway, has been proven to protect the lung against various pathological stimuli. The present study aimed to investigate the effect of SFN on lung injury induced by systemic ischemia reperfusion after cardiac arrest and resuscitation.Methods: After animal preparation, 24 pigs were randomly divided into sham group (n = 6), cardiopulmonary resuscitation group (CPR, n = 9), or CPR + SFN group (n = 9). The experimental model was then established by 10 min of cardiac arrest followed by 6 min of CPR. Once spontaneous circulation was achieved, a dose of 2 mg/kg of SFN diluted in 20 mL of saline was intravenously infused with a duration of 5 min. During 4 h of observation after resuscitation, extravascular lung water index (ELWI), pulmonary vascular permeability index (PVPI), and oxygenation index were regularly evaluated. At 24 h after resuscitation, lung tissues were harvested to evaluate the score of lung histopathological injury, the activity of superoxide dismutase, the contents of malondialdehyde, IL-1 beta, and IL-18, and the expression levels of NOD-like receptor pyrin domain 3, cleaved caspase 1, gasdermin D (GSDMD), GSDMD N-terminal, Nrf2, and HO-1.Results: During CPR, spontaneous circulation was achieved in six and seven pigs in the CPR and CPR + SFN groups, respectively. After resuscitation, the indicators of lung injury (ELWI, PVPI, and oxygenation index) were all better in the CPR + SFN group than in the CPR group, in which the differences in ELWI and PVPI at 2, and 4 h after resuscitation were significant between the two groups. In addition, SFN significantly reduced lung injury score, improved oxidative imbalance (superoxide dismutase, malondialdehyde), decreased pyroptosis-related proinflammatory cytokines (IL-1 beta, IL-18), downregulated pyroptosis-related proteins (NOD-like receptor pyrin domain 3, cleaved caspase 1, GSDMD, GSDMD N-terminal), and activated the Nrf2/HO-1 pathway when compared with the CPR group.Conclusion: SFN produced effective postresuscitation lung protection through alleviating lung pyroptosis possibly via activating the Nrf2/HO-1 pathway in pigs.
引用
收藏
页码:427 / 433
页数:7
相关论文
共 50 条
  • [31] Naringenin Alleviates Renal Ischemia Reperfusion Injury by Suppressing ER Stress-Induced Pyroptosis and Apoptosis through Activating Nrf2/HO-1 Signaling Pathway
    Zhang, Banghua
    Wan, Shanshan
    Liu, Hao
    Qiu, Qiangmin
    Chen, Hui
    Chen, Zhiyuan
    Wang, Lei
    Liu, Xiuheng
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [32] 18β-glycyrrhetinic acid alleviates radiation-induced skin injury by activating the Nrf2/HO-1 signaling pathway
    Wang, Zeng
    Chen, Ruiqing
    Chen, Junying
    Su, Li
    BIOLOGICAL CHEMISTRY, 2024, 405 (06) : 407 - 415
  • [33] Obacunone Alleviates Inflammatory Pain by Promoting M2 Microglial Polarization and by Activating Nrf2/HO-1 Signaling Pathway
    Nan, Fubei
    Tian, Qingxin
    Chen, Shuangdong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 1265 - 1275
  • [34] Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway
    Yuan Zhao
    Gao-Yin Kong
    Wan-Min Pei
    Bo Zhou
    Qin-Qin Zhang
    Bing-Bing Pan
    European Cytokine Network, 2019, 30 : 88 - 97
  • [35] Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway
    Zhao, Yuan
    Kong, Gao-Yin
    Pei, Wan-Min
    Zhou, Bo
    Zhang, Qin-Qin
    Pan, Bing-Bing
    EUROPEAN CYTOKINE NETWORK, 2019, 30 (03) : 88 - 97
  • [36] Nicotinamide adenine dinucleotide phosphate alleviates intestinal ischemia/reperfusion injury via Nrf2/HO-1 pathway
    Chen, Su-ying
    Xu, Hui
    Qin, Yan
    He, Tian-qi
    Shi, Rui-rui
    Xing, Yu-run
    Xu, Jian
    Cong, Ruo-chen
    Wang, Mei-rong
    Yang, Ju-shun
    Gu, Jin-hua
    He, Bo-sheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
  • [37] Albiflorin alleviates neuroinflammation of rats after MCAO via PGK1/Nrf2/ HO-1 signaling pathway
    Ou, Zhijie
    Li, Peiyi
    Wu, Lili
    Wu, Yan
    Qin, Lina
    Fang, Li
    Xu, Hong
    Pei, Ke
    Chen, Juping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 137
  • [38] Vitamin C Inhibited Pulmonary Metastasis through Activating Nrf2/HO-1 Pathway
    Man, Shuli
    Bi, Jingxian
    Liu, Furui
    Xie, Wenwen
    Ma, Long
    MOLECULAR NUTRITION & FOOD RESEARCH, 2024, 68 (06)
  • [39] Melatonin attenuates LPS-induced pyroptosis in acute lung injury by inhibiting NLRP3-GSDMD pathway via activating Nrf2/HO-1 signaling axis
    Kang, Jia-Ying
    Xu, Meng-Meng
    Sun, Ying
    Ding, Zhen-Xing
    Wei, Yuan-Yuan
    Zhang, Da-Wei
    Wang, Yue-Guo
    Shen, Ji-Long
    Wu, Hui-Mei
    Fei, Guang-He
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 109
  • [40] Quercetin Ameliorates Diabetic Kidney Injury by Inhibiting Ferroptosis via Activating Nrf2/HO-1 Signaling Pathway
    Feng, Qi
    Yang, Yang
    Qiao, Yingjin
    Zheng, Yifeng
    Yu, Xiaoyue
    Liu, Fengxun
    Wang, Hui
    Zheng, Bin
    Pan, Shaokang
    Ren, Kaidi
    Liu, Dongwei
    Liu, Zhangsuo
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2023, 51 (04): : 997 - 1018